远大控股(000626) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥20,164,110,380.86, representing a 22.58% increase year-over-year[3]. - Net profit attributable to shareholders for the same period was ¥81,421,377.39, a significant increase of 73.93% compared to the previous year[3]. - The basic earnings per share for Q3 2021 was ¥0.16, reflecting an 85.61% increase year-over-year[3]. - In the first three quarters of 2021, the company achieved operating revenue of CNY 60.08 billion, an increase of 50.84% compared to the same period last year[13]. - The net profit attributable to shareholders of the listed company was CNY 2.14 billion, turning from a loss of CNY 0.52 billion in the same period last year, representing a growth of 508.64%[13]. - Total operating revenue for the current period reached ¥60,078,565,970.03, a significant increase of 50.8% compared to ¥39,828,721,919.73 in the previous period[25]. - Net profit for the current period was ¥261,956,084.21, a turnaround from a net loss of ¥482,786.39 in the previous period[26]. - The profit attributable to the parent company's shareholders was ¥213,511,259.22, compared to a loss of ¥52,248,872.42 in the same period last year[26]. - Earnings per share (basic and diluted) improved to ¥0.41 from a loss of ¥0.10 in the previous period[27]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥8,521,954,349.32, marking a 28.85% increase from the end of the previous year[3]. - The total assets of the company as of September 30, 2021, were CNY 85.22 billion, an increase of 28.85% from the end of the previous year[13]. - The company’s total current assets increased to approximately CNY 7.53 billion as of September 30, 2021, compared to CNY 6.07 billion at the end of 2020, reflecting a growth of about 24.1%[21]. - The company’s total liabilities increased to approximately CNY 4.98 billion as of September 30, 2021, compared to CNY 3.65 billion at the end of 2020, indicating a growth of about 36.5%[22]. - Total liabilities increased to ¥5,385,132,008.05 from ¥3,796,158,878.80, indicating a growth of 42%[26]. - Total liabilities amounted to CNY 3,796,158,878.80, with current liabilities at CNY 3,647,163,716.33[35]. - Non-current liabilities totaled CNY 148,995,162.47, including lease liabilities of CNY 80,999,995.79[35]. Cash Flow - The company reported a cash flow from operating activities of ¥307,949,261.94, which is a 167.68% increase year-to-date[3]. - The company reported a cash flow from operating activities of CNY 307.95 million, a turnaround from a negative cash flow of CNY 455.02 million in the same period last year, representing a growth of 167.68%[12]. - Cash generated from operating activities was ¥66,108,607,914.03, an increase from ¥44,767,061,249.95 in the prior period[29]. - The net cash flow from operating activities was CNY 307,949,261.94, a significant improvement compared to a negative cash flow of CNY -455,019,204.43 in the same period last year[30]. - The total cash inflow from investment activities reached CNY 8,663,411,829.92, up from CNY 6,026,619,609.68 year-over-year[30]. - The net cash flow from financing activities was CNY 360,188,841.29, compared to CNY 129,678,510.36 in the previous year, indicating a positive trend in financing[31]. - The total cash and cash equivalents at the end of the period amounted to CNY 2,409,527,305.21, an increase from CNY 1,880,779,075.19 at the end of the previous year[31]. - The company reported a total investment cash outflow of CNY 8,025,084,423.01, compared to CNY 5,532,926,608.29 in the previous year, indicating increased investment activity[30]. Equity - The company’s total equity attributable to shareholders increased by 9.91% to ¥2,901,900,767.26 compared to the end of the previous year[3]. - The company's equity attributable to shareholders of the listed company was CNY 29.02 billion, up 9.91% from the end of the previous year[13]. - Total equity reached CNY 2,817,927,637.64, with equity attributable to shareholders of the parent company at CNY 2,640,159,069.96[35]. - The company reported an unallocated profit of CNY 837,293,855.00 within its equity structure[35]. Investments and Acquisitions - Fixed assets increased by 135.51% to ¥265,250,401.29, primarily due to the acquisition of Fujian Kaili Biological Products Co., Ltd.[8]. - The company acquired an 85.1166% stake in Fujian Kaili, a high-tech enterprise engaged in the R&D, production, and sales of biopesticide raw materials and formulations, which holds a patent for Zhongshengmycin raw materials[15]. - The company plans to integrate and acquire in the ecological agriculture sector, focusing on product research and application technology innovation[14]. - The company aims to enhance its oil and fat industry chain by establishing long-term partnerships with local enterprises through overseas asset acquisitions and joint ventures, focusing on stable and traceable oil material supply[16]. Strategic Initiatives - The company aims to combine trade with high technology, striving to become a large integrated enterprise in trade and industry[14]. - The company has established strategic partnerships with several Fortune 500 companies, maintaining a leading position in the bulk commodity trading sector[14]. - The company emphasizes the innovation and product layout in biopesticide research and development, collaborating with the Chinese Academy of Agricultural Sciences to establish an ecological agriculture R&D center[15]. Other Information - The company’s subsidiary, Yuanda Oil (Dongguan) Co., Ltd., was approved to become a designated delivery warehouse for palm oil at the Dalian Commodity Exchange[16]. - The company received approval from the China Securities Regulatory Commission for a non-public issuance of A-shares, indicating ongoing capital-raising efforts[17]. - The report for the third quarter of 2021 was not audited[36].